MiniMed Group, Inc. (MMED)
NASDAQHealth CareMedical - Equipment & ServicesSnapshot 2026-11-04
$19.29+2.33%
Close 2026-11-04 · 1-day change
NASDAQHealth CareMedical - Equipment & ServicesSnapshot 2026-11-04
QuarterlyIQ Insights · MMED
How strong the business is — where it ranks within its sector on capital efficiency and cash generation, and how well management has been executing.
How management runs the business: capital, margins, balance sheet, and how reliably they guide and deliver.
A guidance track record builds as the company issues and delivers on guidance.
Priorities management has stated in recent disclosures, with status and evidence drawn from earnings calls, filings, and press releases.
Q1 Results • Strong double-digit net sales growth, ahead of expectations, on U.S. net sales growth acceleration and continued robust international net sales growth, even when excluding extra week ben…
Stated in 1 of 1 supplied quarters. Management reported: “(3) The three months ended July 31, 2026, excludes $14 million of revenue adjustments related to favorable currency impact on net sales, and a $7 million benefit from Q1 FY26 related to the Italian payback accrual.” “The currency impact to net sales measures the change in net sales between current and prior year periods using constant exchange rates.” Revenue was $790.000 million in 2026-Q3.
Each factor is a parallel diagnostic with a clear read of what it shows and how names like it have historically fared. Never aggregated into a single score.
Operating income rose in 1 of the last 3 quarter-over-quarter moves. Historically, Health Care names rated neutral grew net income 51% of the time over the next year (vs 41% for the rest of the cohort, n=13498).
Not enough signal yet.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
“Q1 Results • Strong double-digit net sales growth, ahead of expectations, on U.S. net sales growth acceleration and continued robust international net sales growth, even when excluding extra week ben…”
“The U.S. launch of MiniMed Flex™ is doing exactly what we designed it to do: bringing new patients into the MiniMed ecosystem, driving competitive conversions, and generating significant new account…
Stated in 1 of 1 supplied quarters. Management reported: “(3) The three months ended July 31, 2026, excludes $14 million of revenue adjustments related to favorable currency impact on net sales, and a $7 million benefit from Q1 FY26 related to the Italian payback accrual.” “The currency impact to net sales measures the change in net sales between current and prior year periods using constant exchange rates.”
““The U.S. launch of MiniMed Flex™ is doing exactly what we designed it to do: bringing new patients into the MiniMed ecosystem, driving competitive conversions, and generating significant new account…”
Document Exhibit 99.1 NEWS RELEASE FOR IMMEDIATE RELEASE MiniMed Delivers Strong Start to Fiscal Year 2027 with U.S. Growth Acceleration • Strong start to fiscal year with net sales of $843 million g…
Stated in 1 of 1 supplied quarters. Management reported: “(3) The three months ended July 31, 2026, excludes $14 million of revenue adjustments related to favorable currency impact on net sales, and a $7 million benefit from Q1 FY26 related to the Italian payback accrual.” “The currency impact to net sales measures the change in net sales between current and prior year periods using constant exchange rates.”
“Document Exhibit 99.1 NEWS RELEASE FOR IMMEDIATE RELEASE MiniMed Delivers Strong Start to Fiscal Year 2027 with U.S. Growth Acceleration • Strong start to fiscal year with net sales of $843 million g…”
U.S. New Pumps Sold (NPS) grew over 20% year over year, driven by MiniMed Flex™ and new sensor launches • Worldwide NPS of ~34,000, an increase of 7.7% year over year • Worldwide CGM Attachment Rate…
Stated in 1 of 1 supplied quarters. Management reported: “(3) The three months ended July 31, 2026, excludes $14 million of revenue adjustments related to favorable currency impact on net sales, and a $7 million benefit from Q1 FY26 related to the Italian payback accrual.” “The currency impact to net sales measures the change in net sales between current and prior year periods using constant exchange rates.” Operating income was $-100.000 million in 2026-Q3.
“U.S. New Pumps Sold (NPS) grew over 20% year over year, driven by MiniMed Flex™ and new sensor launches • Worldwide NPS of ~34,000, an increase of 7.7% year over year • Worldwide CGM Attachment Rate…”
Continue the commercialization and U.S. launch of the MiniMed Flex insulin pump, expanding patient base and ecosystem integration.
Not enough signal yet.
Not enough signal to read sensitivity to the US dollar, the broad stock market, long-term interest rates, real (inflation-adjusted) rates, Fed net liquidity (low R² over the window).
12 material management or governance events in the past 24 months, led by executive changes. Historically, Health Care names rated neutral grew net income 46% of the time over the next year (vs 44% for the rest of the cohort, n=13229).
Not investment advice. As of 2026-11-04.